Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Lobeglitazone in Drug-Naive Patients with Type 2 Diabetes

被引：0
|
作者：
Kim, Kyoung Min
Lee, Seo Young
Lee, Ji Hyun
Lee, Dong Hwa
Oh, Tae Jung
Jang, Hak Chul
Lim, Soo
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1290-P
引用
收藏
页码：A346 / A346
页数：1
相关论文
共 50 条
  • [21] The Safety and Tolerability of Metformin plus Colesevelam in Drug-Naive Patients with Early Type 2 Diabetes Mellitus
    Abby, Stacey L.
    Garvey, W. Timothy
    Handelsman, Yehuda
    Fonseca, Vivian A.
    Goldberg, Ronald B.
    Rosenstock, Julio
    Jones, Michael R.
    Markiewicz, Magdalena
    Jin, Xiaoping
    Misir, Soamnauth
    Nagendran, Sukumar
    [J]. DIABETES, 2010, 59 : A173 - A173
  • [22] The Efficacy of Teneligliptin with Metformin in Drug-Naive Type 2 Subjects
    Chudasama, Dipak B.
    Saboo, Banshi D.
    Panchal, Dharmendra
    Patel, Feny
    Saiyed, Mahira
    Hasnani, Dhruvi
    Chavda, Vipul
    Chandarana, Hardik
    Goklani, Rutul
    [J]. DIABETES, 2018, 67
  • [23] Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naive Patients with Type 2 Diabetes: Comparison with Metformin
    Goeke, B.
    Hershon, K.
    Kerr, D.
    Calle Pascual, A.
    Schweizer, A.
    Foley, J.
    Shao, Q.
    Dejager, S.
    [J]. HORMONE AND METABOLIC RESEARCH, 2008, 40 (12) : 892 - 895
  • [24] Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naive Type 2 Diabetes
    Rosenstock, Julio
    Chuck, Leonard
    Gonzalez-Ortiz, Manuel
    Merton, Kate
    Craig, Jagriti
    Capuano, George
    Qiu, Rong
    [J]. DIABETES CARE, 2016, 39 (03) : 353 - 362
  • [25] Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
    Aschner, P.
    Katzeff, H. L.
    Guo, H.
    Sunga, S.
    Williams-Herman, D.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (03): : 252 - 261
  • [26] Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naive Japanese patients with type 2 diabetes
    Ohta, Akio
    Ohshige, Toshihiko
    Sakai, Kensuke
    Nakamura, Yuta
    Tenjin, Ayumi
    Tsukiyama, Shuichi
    Terashima, Yuko
    Matsubara, Fumiaki
    Kawata, Takehiro
    Nagai, Yoshio
    Tanaka, Yasushi
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (17) : 2315 - 2322
  • [27] Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study
    Hong, Jun Hwa
    Moon, Jun Sung
    Seong, Kayeon
    Lim, Soo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 203
  • [28] Initial combination therapy with saxagliptin and metformin improves glycaemic control compared with either monotherapy alone in drug-naive patients with type 2 diabetes
    Chen, R.
    Pfuetzner, A.
    Jadzinsky, M.
    Paz-Pacheco, E.
    Xu, Z.
    Allen, E.
    [J]. DIABETOLOGIA, 2008, 51 : S38 - S38
  • [29] Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
    Ballav, Chitrabhanu
    Gough, Stephen C. L.
    [J]. CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2013, 6 : 25 - 37
  • [30] Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes and metabolic syndrome over 24-weeks
    Kim, D.
    Kim, S.
    Yoon, K.
    Chun, S.
    Park, K.
    Choi, K.
    Lim, S.
    Mok, J.
    Lee, H.
    Seo, J.
    Cha, B.
    Kim, M. -K.
    Shon, H.
    Choi, D.
    [J]. DIABETOLOGIA, 2019, 62 : S428 - S428
12345